Strata Skin Sciences (NASDAQ:SSKN – Get Free Report) and Privia Health Group (NASDAQ:PRVA – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, analyst recommendations and risk.
Insider & Institutional Ownership
32.4% of Strata Skin Sciences shares are held by institutional investors. Comparatively, 94.5% of Privia Health Group shares are held by institutional investors. 39.0% of Strata Skin Sciences shares are held by company insiders. Comparatively, 10.7% of Privia Health Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Analyst Ratings
This is a summary of current recommendations and price targets for Strata Skin Sciences and Privia Health Group, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Strata Skin Sciences | 0 | 0 | 1 | 0 | 3.00 |
| Privia Health Group | 0 | 2 | 11 | 1 | 2.93 |
Profitability
This table compares Strata Skin Sciences and Privia Health Group’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Strata Skin Sciences | -35.13% | -266.94% | -32.66% |
| Privia Health Group | 0.78% | 2.13% | 1.25% |
Valuation and Earnings
This table compares Strata Skin Sciences and Privia Health Group”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Strata Skin Sciences | $33.56 million | 0.17 | -$10.09 million | ($2.84) | -0.49 |
| Privia Health Group | $1.74 billion | 1.58 | $14.39 million | $0.11 | 202.91 |
Privia Health Group has higher revenue and earnings than Strata Skin Sciences. Strata Skin Sciences is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.
Risk & Volatility
Strata Skin Sciences has a beta of 0.56, indicating that its share price is 44% less volatile than the S&P 500. Comparatively, Privia Health Group has a beta of 0.82, indicating that its share price is 18% less volatile than the S&P 500.
Summary
Privia Health Group beats Strata Skin Sciences on 12 of the 15 factors compared between the two stocks.
About Strata Skin Sciences
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.
About Privia Health Group
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.
Receive News & Ratings for Strata Skin Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strata Skin Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
